Discover the full insider trade history of 睿昂基因, a listed equity based in France. Shares are listed on FR FR, under the authority of AMF. Market capitalisation: €1.5bn. The latest transaction was disclosed on 12 September 2023 — Sale. Among the most active insiders: 柯中和. The full history is openly available.